Back
Intra-Cellular Therapies Stock Price Chart
Sell
40
ITCI
Intra-Cellular Therapies
Last Price:
65.45
Seasonality Move:
-0.94%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.76 | Sell |
| 20-day SMA: | 70.02 | Sell |
| 50-day SMA: | 68.75 | Sell |
| 200-day SMA: | 62.74 | Buy |
| 8-day EMA: | 67.09 | Sell |
| 20-day EMA: | 68.63 | Sell |
| 50-day EMA: | 69 | Sell |
| 200-day EMA: | 64.65 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.11 | Sell |
| Relative Strength Index (14 RSI): | 43.73 | Sell |
| Chaikin Money Flow: | 207665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.48 - 74.3) | Sell |
| Bollinger Bands (100): | (66.15 - 72.27) | Sell |
Intra-Cellular Therapies Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 66.53 while ITCI 8-day simple moving average is 66.76, which is a Sell signal.
- The stock price of ITCI is 66.53 while Intra-Cellular Therapies 20-day SMA is 70.02, which makes it a Sell.
- Intra-Cellular Therapies 50-day simple moving average is 68.75 while ITCI share price is 66.53, making it a Sell technically.
- ITCI stock price is 66.53 and Intra-Cellular Therapies 200-day simple moving average is 62.74, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
40
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $66.53. The Score for ITCI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
7.02B
Price in USD:
66.53
Share Volume:
723.4K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
40
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 66.53 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 66.53 while ITCI 8-day exponential moving average is 67.09, which is a Sell signal.
- The stock price of ITCI is 66.53 while Intra-Cellular Therapies 20-day EMA is 68.63, which makes it a Sell.
- Intra-Cellular Therapies 50-day exponential moving average is 69.00 while ITCI share price is 66.53, making it a Sell technically.
- ITCI stock price is 66.53 and Intra-Cellular Therapies 200-day simple moving average is 64.65, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.44 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is -1.11, suggesting Intra-Cellular Therapies is a Sell
- Intra-Cellular Therapies Relative Strength Index (RSI) is 43.73, which suggest Intra-Cellular Therapies is oversold
- The Bollinger Bands (25) for Intra-Cellular Therapies is (66.48 - 74.3), which suggest Intra-Cellular Therapies is a Sell
- The Bollinger Bands (100) for Intra-Cellular Therapies is (66.15 - 72.27), which suggest Intra-Cellular Therapies is a Sell
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.